Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): A case report and review of the literature

Department of Pathology, University of Miami, Miller School of Medicine--Jackson Memorial Hospital, 1611 NW 12th Avenue, Holtz Building, Room 2042 G, Miami, FL 33136, USA.
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (Impact Factor: 2.65). 10/2006; 449(3):376-81. DOI: 10.1007/s00428-006-0251-0
Source: PubMed


We describe a rare hepatic collision tumor composed of a hepatocellular carcinoma and a high-grade neuroendocrine carcinoma. The patient, a 50-year-old man, underwent a partial hepatectomy because of a 5.0-cm mass. The tumor had two distinctive patterns. The majority of the tumor was a high-grade neuroendocrine carcinoma with features of a small cell carcinoma that was positive for chromogranin, synaptophysin, and cytokeratin 19 and negative for hepatocellular antigen and alpha-fetoprotein (AFP). The second component was a moderately differentiated hepatocellular carcinoma that was positive for hepatocellular antigen and AFP and negative for neuroendocrine markers. The two tumors were separated by fibrous bands. In areas where they collided, there was no transition or intermingling of cells between the two components, thus, it is different from the combined type of tumors. After removal of the tumor, the patient had intrahepatic and mesenteric recurrences within a follow-up period of 16 months.

12 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Résumé Nous rapportons une observation d’un carcinome hépatocellulaire (CHC) avec contingent cellulaire de type neuroendocrine. Il s’agit d’un patient âgé de 56 ans, ayant consulté pour une distension abdominale. L’examen physique a mis en évidence une ascite. Le bilan biologique était normal à l’exception de l’alphafoetoprotéine élevée à 70 ng/ml. Les sérologies virales des hépatites B et C étaient négatives. Les examens échographique et tomodensitométrique montraient de multiples nodules hépatiques du segment postérieur associés à des ganglions des chaînes hépatiques communes et coeliomésentériques. Une biopsie hépatique chirurgicale a été effectuée. Elle a montré à l’examen anatomopathologique une prolifération tumorale répondant à un CHC moyennement différencié, au sein duquel on notait un contingent cellulaire représentant environ 10 % du prélèvement tumoral et répondant à un carcinome de type neuroendocrine. Le patient n’a pas eu de traitement et décède un mois après le diagnostic.
    Journal africain du cancer / African Journal of Cancer 05/2011; DOI:10.1007/s12558-011-0175-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: The diagnosis of hepatocellular carcinoma (HCC) is based on classic histologic findings. However, some cases may need additional studies to clarify the origin of the neoplasm or confirm its malignant nature. Immunohistochemistry is useful not only in determining the hepatic origin but also in ruling out potential metastatic malignancies, and can also aid in distinguishing benign and malignant hepatic neoplasms The aim of this study is to review the utilities and potential pitfalls of the most commonly used markers. We reviewed the English literature published from 1986 to 2008 and considered pattern of staining, cross reaction with tissues other than hepatocytes, sensitivity, and specificity for each potentially useful antibody. In the last 20 years, innumerable immunomarkers have been studied in HCC but only a few of them are helpful on a daily basis. Among all the markers hepatocyte paraffin 1, polyclonal CEA antibody (canalicular pattern), and glypican-3 are the most sensitive and specific markers of HCC. MOC-31, Ber-ep4, epithelial membrane antigen, CD15, and mCEA are usually not expressed in the tumoral cells. Vascular markers stain sinusoidal lining cells and can aid in the distinction between benign and malignant hepatic lesions.
    Pathology Case Reviews 12/2008; 14(1):40-46. DOI:10.1097/PCR.0b013e31819c4c4f
  • [Show abstract] [Hide abstract]
    ABSTRACT: Collision tumors are rare tumors composed of two histologically distinct neoplasms coinciding at the same location. Collision tumors need to be distinguished from tumors originating from a progenitor cell with potential for multiphenotypic differentiation. A clinically puzzling case of an intricate malignant pulmonary nodule in a patient with previous history of colorectal carcinoma is reported. A brief review of the clinical literature on collision tumor and tumor stem cells is presented. This case report emphasizes the importance of detailed histopathologic and immunohistochemical analyses, and clinical history in diagnosing a tumor composed of multiple malignant morphologies.
    Anticancer research 06/2009; 29(5):1495-7. · 1.83 Impact Factor
Show more